Clinical Trial Update: Phase II Study of ABI-007 for Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase II study of ABI-007 in gastric cancer, sponsored by Taiho Pharmaceutical, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• ABI-007 (nab-paclitaxel)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED